[DOI] [PMC free article] [PubMed] [Google Scholar] 119.Lee Y.S., Kim T.Y., Kim Y., Lee S.H., Kim S., Kang S.W., Yang J.Y., Baek I.J., Sung Y.H., Park Y.Y., et al
This proactive approach also gives your obstetrician full context about your recent medication history and any metabolic patterns they should monitor during prenatal care
In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
Large studies have shown they also: Reduce the risk of heart attacks by about 20% Lower the chance of strokes Decrease heart failure hospitalizations Reduce overall cardiovascular death Some of these benefits happen independently of blood pressure changes, which means GLP-1 medications protect your heart through multiple pathways
Genetics, hormones and variability in how the brain regulates energy can all influence weight and a persons response to the drugs, Stanford said
Those are the top three nutritional advice pieces for someone starting on a GLP-1